Everyday Care in Action: Thousands of Kenvue Employees Come Together Across 21 Markets to Help Advance Healthier Communities
Kenvue Inc. (NYSE: KVUE), the maker of iconic brands such asNeutrogena®, Listerine®, Aveeno®, and Tylenol®, today announced its global community engagement efforts in celebration of Kenvue Cares Week, the company’s signature annual volunteer initiative part of its Healthy Lives Mission. Kenvue Cares Week is a testament to the strong Kenvue commitment to advance the well-being of people and our planet, giving back through volunteerism, and delivering meaningful, measurable impact in local communities.
Throughout the month of May, thousands of Kenvuers are coming together in 21 markets across six continents to support causes driven by the company’s commitments, creating 5,000+ hours of meaningful moments, building stronger connections with their communities, and demonstrating the power of everyday care in action. This marks a fourfold increase in site participation compared to the program’s inaugural year. This year, Kenvuers will help deliver approximately 22,000 hygiene kits, curated with over 110,000 products from across our iconic brands, including Neutrogena®, Listerine®, OGX®, Johnson’s® Baby and Aveeno®, to support the health and wellbeing of vulnerable communities, including those affected by natural disasters, homelessness and conflict.
“Kenvue Cares Week is a powerful example of our Purpose – realize the extraordinary power of everyday care - in action. Our more than 20,000 Kenvuers share a passion for bringing everyday care to life for our consumers and communities and we are proud of the impact we are helping deliver,” said Russell Dyer, Chief Corporate Affairs Officer, Kenvue.
“Save the Children has been working for over 100 years to ensure all children have a healthy start in life, the opportunity to learn, and protection from harm," said Luciana Bonifacio, Chief Development Officer of Save the Children U.S. "We can't achieve this ambitious mission alone, and the support of strategic partners like Kenvue is essential for building lasting change for kids in the U.S. and around the world. This Kenvue Cares Week, we're proud to come together for a shared purpose—to make a difference for the wellbeing of children and communities in the aftermath of crises."
“Kenvue Cares Week presents the ideal opportunity to strengthen our mission at GRACE to care for our community through direct service. The sharing of personal care products plays an essential role in our efforts to support the underserved and help our neighbors take care of themselves,” said Amanda Block, Founder and Director, GRACE, a Summit based nonprofit focused on meeting the needs of underserved neighbors with community resources.
Advancing Healthy Communities
Examples of the activities Kenvuers will participate in include:
North America
- Pack hygiene kits of Kenvue products for disaster relief with Heart to Heart International in the U.S. and with Save the Children in Canada.
- Plant trees in Guelph and Markham, Canada, to support reforestation.
- Distribute food with local partners GRACE and Bridges Outreach.
- Pack food donations with the Mattie N. Dixon Community Cupboard in Fort Washington, Pennsylvania.
Latin America:
- Build hygiene kits with Save the Children in Cali, Colombia and Mexico City, Mexico, and with Direct Relief in Sao Paulo and San Jose Dos Campos, Brazil.
- Build sanitary bathrooms and help promote hygiene habits with local partner Modulo Sanitario in Buenos Aires, Argentina.
- Renovate playgrounds at children’s villages with Aldeas Infantiles in Asunción, Paraguay.
Europe, Middle East, and Africa:
- Pack hygiene kits with Save the Children in Cape Town, South Africa; Spain, Madrid, and with In Kind Direct in high Wycombe, England.
- Participate in "plogging" (jogging and picking up litter at the same time) in Rotkreuz, Switzerland Host an Equity in STEM workshop in High Wycombe, England.
Asia-Pacific:
- Assemble hygiene kits with Save the Children in Sydney, Australia, Beijing, and Shanghai, China.
- Plant trees on Motuihe Island in Auckland, New Zealand.
- Support elderly care centers in Singapore through NTUC Health Day Care Centre.
- Pack food kits with the India Food Banking Network in Baddi and Mulund, India.
About Kenvue
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, statements about management’s expectations of Kenvue’s future operating and financial performance, product development, market position and business strategy. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates. A list and descriptions of these risks, uncertainties and other factors can be found in Kenvue’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Any forward-looking statement made in this release speaks only as of the date of this release. Kenvue undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250514740041/en/
Contacts
Melissa Witt
media@kenvue.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS3.7.2025 15:59:00 EEST | Press release
Today, Venture Global, Inc. (NYSE: VG) announced the execution of a new 20-year Sales and Purchase Agreement (SPA) with PETRONAS LNG Ltd. (PLL), a subsidiary of the Malaysian state-owned oil and gas company, PETRONAS. Under the terms of the SPA, PETRONAS will purchase 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global’s third facility, CP2 LNG, for 20 years. This builds upon Venture Global’s existing agreement with PETRONAS for 1 MTPA of LNG supply from Plaquemines LNG. PETRONAS, a world-class partner in the LNG industry, joins other CP2 LNG customers in Europe, Asia and the rest of the world in a strategically important project to global energy supply and security. To date, approximately 10.75 MTPA of the 14.4 MTPA nameplate capacity for CP2 Phase One has been sold. About Venture Global Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets ac
Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 15:05:00 EEST | Press release
In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for
Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model3.7.2025 13:02:00 EEST | Press release
The novel compound AC102 almost completely reversed tinnitus in a preclinical model after a single dose. At the same time, the damaged connections between the auditory nerve and inner ear sensory cells were restored. These findings were recently published in the prestigious International Journal of Molecular Sciences in a joint study conducted by Erlangen University Hospital and Berlin-based drug developer AudioCure. As there is currently no causal treatment for tinnitus, there is a high medical need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702168211/en/ In 10-20% of tinnitus cases, the noise in the ear is so severe that it significantly impairs the quality of life of those affected. (Source: AI-generated) In the current study, AC102 was administered to the middle ear of one experimental group after acoustic trauma, while a second group received a placebo. Although both groups initially showed signs of tinnitus, th
H2SITE Secures EIC Accelerator Funding to Deploy a Flagship 1 TPD Ammonia Cracker Using Membrane Reactor Technology at a Port in North-West Europe3.7.2025 09:40:00 EEST | Press release
H2SITE has been awarded the EIC (European Innovation Council) Accelerator program for a project aimed at deploying a first-of-its-kind ammonia cracking unit capable of producing 1 ton of high-purity hydrogen per day. The system is based on H2SITE’s proprietary palladium-based membrane reactor technology, which enables the simultaneous catalytic decomposition of ammonia and selective hydrogen separation within a single unit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702142283/en/ Ammonia Cracker using Membrane Reactor Technology This breakthrough technology offers several compelling advantages over conventional ammonia cracking processes: Lowest Levelized Cost of Hydrogen (LCOH) from ammonia due to high efficiency and integrated operation Reduced energy consumption, operating at significantly lower temperatures (400–450 °C) than traditional cracking methods (typically 600–800 °C) High-purity hydrogen output, compliant
ISDA and Ant International Lead New Industry Report on Use of Tokenised Bank Liabilities for FX Settlement and Cross-Border Payments Under Project Guardian3.7.2025 09:00:00 EEST | Press release
The International Swaps and Derivatives Association (ISDA) and Ant International led the Project Guardian FX industry group to develop a new report for implementing tokenised bank liabilities and shared ledger in cross-border payments and foreign exchange (FX) settlement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702791535/en/ Report on Use of Tokenised Bank Liabilities for Transaction Banking by ISDA and Ant International, under the Monetary Authority of Singapore's (MAS) Project Guardian The joint report is produced under the Monetary Authority of Singapore's (MAS) Project Guardian, a global collaboration between policymakers and key industry players to enhance liquidity and efficiency of financial markets through asset tokenisation. ISDA and Ant International are members of the industry group and lead the FX workstream to develop FX data specifications, risk management frameworks and FX documentation. Other contri
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom